Halozyme TherapeuticsHALO 
$48.601.19%24h
1.19%24h
Global rank941
Market cap$6.42B
Change 7d-1.30%
YTD Performance31.96%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Halozyme Therapeutics (HALO)
As of December 2024, Halozyme Therapeutics has a market cap of $6.42B. This makes Halozyme Therapeutics the world's 941th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Halozyme Therapeutics from 2004 to 2024
-
Value:-
Market cap history of Halozyme Therapeutics from 2004 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $4.71B | -3.46% |
| 2023 | $4.88B | -35.04% |
| 2022 | $7.52B | 41.51% |
| 2021 | $5.31B | -5.85% |
| 2020 | $5.64B | 140.89% |
| 2019 | $2.34B | 21.19% |
| 2018 | $1.93B | -27.79% |
| 2017 | $2.68B | 105.06% |
| 2016 | $1.31B | -42.99% |
| 2015 | $2.29B | 79.59% |
| 2014 | $1.27B | -35.62% |
| 2013 | $1.98B | 123.40% |
| 2012 | $886.38M | -29.44% |
| 2011 | $1.26B | 20.08% |
| 2010 | $1.05B | 34.92% |
| 2009 | $775.42M | 4.82% |
| 2008 | $739.75M | -21.24% |
| 2007 | $939.22M | -11.68% |
| 2006 | $1.06B | 342.31% |
| 2005 | $240.42M | -17.27% |
| 2004 | $290.62M | - |
HALO Market Cap Today is $6.42B 1.19% - 18 Dec 2024
View largest stocks by market cap 
